Aaron Cowen Suvretta Capital Management
Aaron Cowen is the founder of Suvretta Capital Management, a long/short equity firm with a fundamental research process. The firm invests across sectors with an emphasis on differentiated fundamental views. Cowen’s disclosures are tracked by investors who follow mid-to-large fundamental hedge funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$58.2M |
| 2 |
Dick's Sporting Goods
DKS
|
+$48.3M |
| 3 |
GE HealthCare
GEHC
|
+$37.1M |
| 4 |
Danaher
DHR
|
+$31.2M |
| 5 |
GE Aerospace
GE
|
+$24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Insmed
INSM
|
+$95.9M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$92.5M |
| 3 |
Microsoft
MSFT
|
+$35.3M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$27.1M |
| 5 |
United Airlines
UAL
|
+$26.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.97% |
| 2 | Technology | 9.89% |
| 3 | Consumer Discretionary | 5.64% |
| 4 | Financials | 4.91% |
| 5 | Communication Services | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Elevance Health
ELV
$86.9B
| – | – |
-2,740
| Closed | -$1.19M |
|
102
Disc Medicine
IRON
$3.06B
| – | – |
-80,000
| Closed | -$3.97M |
|
103
Oric Pharmaceuticals
ORIC
$1.47B
| – | – |
-255,000
| Closed | -$1.42M |
|
104
Roblox
RBLX
$27.4B
| – | – |
-227,710
| Closed | -$13.3M |
|
105
Snowflake
SNOW
$115B
| – | – |
-137,886
| Closed | -$20.2M |
|
106
Sanofi
SNY
$110B
| – | – |
-83,701
| Closed | -$4.64M |
|
107
Trevi Therapeutics
TRVI
$2.56B
| – | – |
-340,164
| Closed | -$2.14M |
|
108
Take-Two Interactive
TTWO
$44.8B
| – | – |
-72,400
| Closed | -$15M |
|
109
Unity
U
$20.7B
| – | – |
-339,560
| Closed | -$6.65M |
|
|
BIOA
110
BioAge Labs
BIOA
$435M
| – | – |
-1,452,336
| Closed | -$5.46M |
|
|
AARD
111
Aardvark Therapeutics
AARD
$149M
| – | – |
-312,500
| Closed | -$2.35M |
|
|
ITCI
112
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-700,904
| Closed | -$92.5M |
|
Similar funds
Aaron Cowen's Q2 2025 Portfolio in Review
As of Q2 2025, Aaron Cowen held 112 positions worth $3.32B, up 23% from $2.69B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Aaron Cowen deployed $387M of net new capital in Q2 2025, opening 12 new positions and adding to 30 existing holdings. Its largest new stake was Dick's Sporting Goods: 260,465 shares worth $51.5M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Insmed, an estimated $95.9M trimmed.
- Aaron Cowen's largest Q2 2025 buy was Dick's Sporting Goods: 260,465 shares worth $51.5M.
- Aaron Cowen added most to Coca-Cola in Q2 2025, an estimated $58.2M increase.
- Aaron Cowen's biggest Q2 2025 reduction was Insmed, cutting an estimated $95.9M.
- Aaron Cowen fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $92.5M.
- Aaron Cowen's ten largest holdings make up 46% of its $3.32B portfolio in Q2 2025.
- Aaron Cowen opened 12 new positions and closed 14 in Q2 2025.
- Aaron Cowen's portfolio value rose 23% quarter-over-quarter to $3.32B.
Based on Suvretta Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.